IFNA1 and chronic obstructive pulmonary disease: Some trials with IFN as a therapy have resulted in unwanted local inflammation and side effects.51 In certain systems, IFN is known to induce inflammation.52 As a therapy for inflammatory disorders such as asthma and COPD, creating further inflammation in the absence of infection may be detrimental rather than beneficial.